Private Equity

Managers

Morphic Therapeutic nets $80 mln Series B

Morphic Therapeutic, a developer of oral integrin therapies, has raised $80 million in Series B financing. Omega Funds and Novo Holdings led the round with participation from other investors that included Invus and EcoR1 Capital.

1 min read · 26 September 2018

Nautilus Venture Partners targets $150 mln for sophomore fund

Nautilus Venture Partners is seeking to raise $150 million for its second fund, according to an SEC filing. The Cupertino, California-based early-stage venture firm focused on helping startups partner with large tech companies.

1 min read · 26 September 2018

Digital health firm Maven pulls in $27 mln Series B

New York City-based Maven, a digital health company, has secured $27 million in Series B funding. Sequoia Capital and Oak HC/FT led the round with participation from return backers Spring Mountain Capital, 14W and Female Founders Fund. In addition to the funding, Sequoia partner Jess Lee and Oak HC/FT partner Nancy Brown will join the Maven board.

1 min read · 26 September 2018

CLSA Capital backs ACT Genomics

Taiwan-based ACT Genomics Holdings Company Limited, an Asia-based DNA sequencing-based cancer solution provider, has raised an undisclosed amount of funding. The investors included CLSA Capital Partners.

1 min read · 26 September 2018

Lytical Ventures collects $20 mln for debut fund

Lytical Ventures, a newly launched New York City-based early-stage venture firm focused on corporate intelligence, has raised $20 million in the first close of its debut fund. The target is $60 million. The fund's anchor investor is Lyrical Partners.

2 min read · 26 September 2018

Proscia nabs $8.3 mln Series A

Philadelphia-based Proscia, a digital pathology platform for cancer diagnosis, has raised $8.3 million in Series A funding. Flybridge Capital Partners led the round with participation from other backers that included Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures and RobinHood Ventures.

1 min read · 26 September 2018

Lyra Therapeutics inks $29.5 mln Series B

Boston-based Lyra Therapeutics Inc, a developer of medicines to treat ear, nose and throat diseases, has secured $29.5 million in Series B financing. Perceptive Advisors led the round with participation from other investors that included RA Capital Management, ArrowMark Partners, Soleus Capital, Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners.

1 min read · 26 September 2018

Redpoint’s Baer on the growth behind Brazilian investing

4 min read · 26 September 2018

Fund Performance: UTIMCO's VC portfolio, 2015 vintage

1 min read · 26 September 2018

Troy Capital, Oaktree Capital affiliate create $200 mln fund for employee, investor liquidity

Troy Capital Group and an Oaktree Capital Management affiliate said they created a $200 million fund to provide loan-based liquidity to employees and investors of pre-IPO private companies. Among Troy's co-founders is Josh Berman, co-founder of MySpace.

3 min read · 25 September 2018

Showing 3,311 to 3,320 of 19,970 results
1…331333…1000